Oncology nurses are familiar with the concept of financial toxicity, which refers to the significant financial burden cancer ...

AUTX-703, a novel, oral KAT2A/B degrader, has received fast track designation for use in relapsed/refractory AML.

Experts discuss the role of supportive therapies, such as antiemetics, nutritional support, and physical activity, in improving outcomes and patient comfort during treatment.

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...

Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

Panelists discuss how they maintain treatment adherence through digital health apps, calendar reminders, and symptom journals while working closely with their care teams to address uncertainties and ...

Panelists discuss how their lived experiences and insights as patients should inform research priorities, treatment development, and care delivery improvements while sharing hopes for a future cure ...

Panelists discuss how they navigated initial treatment confusion by seeking clarification from healthcare providers, consulting patient resources, and connecting with support groups to better ...

Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...

According to Laurence Albiges, MD, PhD, treatment of RCC with cabozantinib, nivolumab, and ipilimumab can cause potentially ...

C, BSN, RN, discussed taking advantage of available resources to provide comprehensive care for patients with breast cancer.

Immune checkpoint inhibitors for patients with cancer may be associated with an increased risk for psoriasis when compared ...